A detailed history of Granite Group Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Granite Group Advisors, LLC holds 8,073 shares of ABBV stock, worth $1.43 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares
8,073
Previous 12,040 32.95%
Holding current value
$1.43 Million
Previous $2.07 Billion 22.8%
% of portfolio
1.02%
Previous 1.56%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$163.84 - $199.33 $649,953 - $790,742
-3,967 Reduced 32.95%
8,073 $1.59 Billion
Q2 2024

Jul 23, 2024

BUY
$154.79 - $180.76 $37,768 - $44,105
244 Added 2.07%
12,040 $2.07 Billion
Q1 2024

May 31, 2024

SELL
$159.82 - $182.1 $12,625 - $14,385
-79 Reduced 0.67%
11,796 $2.15 Billion
Q4 2023

Apr 03, 2024

BUY
$137.6 - $154.97 $1.63 Million - $1.84 Million
11,875 New
11,875 $2.13 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Granite Group Advisors, LLC Portfolio

Follow Granite Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Group Advisors, LLC with notifications on news.